Abstract In this article,recent clinical data of brachytherapy around the world are analyzed and combined with the clinical experience from the author and her research team. The author summarizes the indications,contraindications,target range,dosage,efficacy,and side effects to form a mature brachytherapy regimen. The systematic work may provide a reliable reference for domestic counterparts and be helpful for improving brachytherapy. This article mainly discusses soft tissue sarcomas,skin tumors,pediatric malignancies,isolated lymph node metastasis.
Fund:The National Natural Science Fund (31600679);Project of Science and Technology Department of Jilin Province (20090458);Project of Health and Famliy Planning Commission of Jilin Province (2014ZC054);Bethune Special Research of Science and Technology Department of Jilin Province (20160101079JC);Horizontal Project of Jilin University (2015373)
Cite this article:
Cheng Guanghui. Clinical application of brachytherapy for malignant tumor (3):other malignant tumors[J]. Chinese Journal of Radiation Oncology, 2017, 26(8): 853-856.
Cheng Guanghui. Clinical application of brachytherapy for malignant tumor (3):other malignant tumors[J]. Chinese Journal of Radiation Oncology, 2017, 26(8): 853-856.
[1] Pohar S,Haq R,Liu L,et al. Adjuvant high-dose-rate and low-dose-rate brachytherapy with external beam radiation in soft tissue sarcoma:a comparison of outcomes[J].Brachytherapy,2007,6(1):53-57.DOI:10.1016/j.brachy.2006.11.004. [2] Kaushal A,Citrin D.The role of radiation therapy in the management of sarcomas[J].Surg Clin Nor Am,2008,88(3):629–646.DOI:10.1016/j.suc.2008.03.005. [3] Emory C L,Montgomery C O,Potter B K,et al. Early complications of high-dose-rate brachytherapy in soft tissue sarcoma:a comparison with traditional external-beam radiotherapy[J].Clin Orth Rel Res,2012,470(3):751-758.DOI:10.1007/s11999-011-2106-5. [4] Puri A,Agarwal MG,Patil N,et al. Perioperative interstitial brachytherapy for soft tissue sarcomas:prognostic factors and long-term results of 155 patients[J].Ann Surg Oncol,2007,14(2):560-7.DOI:10.1245/s10434-006-9137-2. [5] Skowronek J.Brachytherapy in the treatment of skin cancer:an overview[J].Post Dermat I Alergol,2015,32(5):362.DOI:10.5114/pdia.2015.54746. [6] Sobjanek M,Dobosz M,Peksa R,et al. Lymphoepithelioma-like carcinoma of the skin in a Polish patient[J].Post Dermat I Alergol,2015,32(1):56-58.DOI:10.5114/pdia.2014.40952. [7] Rio E,Bardet E,Ferron C,et al. Interstitial brachytherapy of periorificial skin carcinomas of the face:a retrospective study of 97 cases[J].Int J Radiat Oncol Biol Phys,2005,63(3):753-757.DOI:10.1016/j.ijrobp.2005.03.027. [8] Locke J,Karimpour S,Young G,et al. Radiotherapy for epithelial skin cancer-International Journal of Radiation Oncology·Biology·Physics[J].Int J Radiat Oncol Biol Phys,2001,51(3):748-755.DOI:org/10.1016/S0360-3016(01)01656-X. [9] Guix B,Finestres F,Tello J,et al. Treatment of skin carcinomas of the face by high-dose-rate brachytherapy and custom-made surface molds[J].Int J Radiat Oncol Biol Phys,2000,47(1):95-102. [10] Konefal JB,Emami B,Pilepich MV.Malignant melanoma:analysis of dose fractionation in radiation therapy[J].Radiology,1987,164(3):607-610. [11] Sause W,Cooper J,Rush S,et al. Fraction size in external beam radiation therapy in the treatment of melanoma[J].Int J Radiat Oncol Biol Phys,1991,20(3):429-432. [12] Hobbs C,Harper J.The use of high dose rate brachytherapy palliation after failed palliative external beam radiotherapy for a cutaneous malignant melanoma of the foot:a case report[J].J Palliat Med,2011,14(4):521-523.DOI:10.1089/jpm.2010.0363. [13] Chaudhuri A,De-Groot C,Seel M,et al. Treatment of regional cutaneous nodular metastases from melanoma using high-dose rate mould brachytherapy[J].J Med Imag Radiat Oncol,2011,55(2):206-212.DOI:10.1111/j.1754-9485.2011.02253.x. [14] Buwalda J,Blank L EC,Schouwenburg PF,et al. The AMORE protocol as salvage treatment for non-orbital head and neck rhabdomyosarcoma in children[J].Eur J Surg Oncol,2004,30(8):884-892.DOI:10.1016/j.ejso.2004.06.005. [15] Magné N,Haie-Meder C.Brachytherapy for genital-tract rhabdomyosarcomas in girls:technical aspects,reports,and perspectives[J].Lancet Oncol,2007,8(8):725-729.DOI:10.1016/S1470-2045(07)70240-1. [16] Healey EA,Shamberger RC,Grier HE,et al. A 10-year experience of pediatric brachytherapy[J].Int J Radiat Oncol Biol Phys,1995,32(2):451-455. [17] Ayan I,Kaytan E,Ayan N.Childhood nasopharyngeal carcinoma:from biology to treatment[J].Lancet Oncol,2003,4(4):13-21. [18] Gonzalez-Motta A,Gonzalez G,Bermudez Y,et al. Pediatric nasopharyngeal cancer:case report and review of the literature[J].Cureus,2016,8(2):e497.DOI:10.7759/cureus.497. [19] Blank LE,Koedooder K,Hn VDG,et al. Brachytherapy as part of the multidisciplinary treatment of childhood rhabdomyosarcomas of the orbit[J].Int J Radiat Oncol Biol Phys,2010,77(5):1463-1469.DOI:10.1016/j.ijrobp.2009.06.015. [20] Haie-Meder C,Morice P,Paris B,et al. Consequences of brachytherapy (BT) on uterine myocontractility[C].GEC/ESTRO/GLAC/ABS Joint Brachytherapy Meeting,2004:S26-S26. [21] Chopra S,Gupta Tagarwal JP,Budrukkar A,et al. Re-irradiation in the management of isolated neck recurrences:current status and recommendations[J].Radiother Oncol,2006,81(81):1-8.DOI:10.1016/j.radonc.2006.08.017. [22] Vermorken JB,Specenier P.Optimal treatment for recurrent/metastatic head and neck cancer[J].Ann Oncol,2010,21 Suppl 7:vii252-261.DOI:10.1093/annonc/mdq453. [23] Cohen EE,Lingen MW,Vokes EE.The expanding role of systemic therapy in head and neck cancer[J].J Clin Oncol,2004,22(9):1743-1752.DOI:10.1200/JCO.2004.06.147. [24] Bartochowska A,Skowronek J,Wierzbicka M,et al. Is there a place for brachytherapy in the salvage treatment of cervical lymph node metastases of head and neck cancers?[J].Brachytherapy,2015,14(6):933-938.DOI:10.1016/j.brachy.2015.07.003. [25] He M,Cheng G,Zhao H,et al. EP-1984:interstitial brachytherapy for the isolated lymph node metastasis from different solid cancers[J].Radiother Oncol,2016,119 Suppl:S938-S939. [26] Collettini F,Schippers AC,Schnapauff D,et al. Percutaneous ablation of lymph node metastases using CT-guided high-dose-rate brachytherapy[J].Br J Radiol,2013,86(1027):699-699.DOI:10.1259/bjr.20130088.
2017, Vol. 26 
